Katrina K. Hoyer, Ph.D.

Affiliations: 
2003 University of California, Los Angeles, Los Angeles, CA 
Google:
"Katrina Hoyer"

Parents

Sign in to add mentor
Michael Teitell grad student 2003 UCLA
 (Mechanisms of lymphomagenesis: TCL1 and galectin -3 mediated proliferation and survival.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Turner CN, Camilo Sanchez Arcila J, Huerta N, et al. (2023) T cell exhaustion dynamics in systemic autoimmune disease. Biorxiv : the Preprint Server For Biology
Turner CN, Mullins GN, Hoyer KK. (2022) CXCR5CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? Frontiers in Medicine. 9: 1034764
Valentine KM, Mullins GN, Davalos OA, et al. (2021) CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties. Journal of Autoimmunity. 123: 102690
Valentine KM, Hoyer KK. (2019) CXCR5+ CD8 T Cells: Protective or Pathogenic? Frontiers in Immunology. 10: 1322
Valentine KM, Davini D, Lawrence TJ, et al. (2018) CD8 Follicular T Cells Promote B Cell Antibody Class Switch in Autoimmune Disease. Journal of Immunology (Baltimore, Md. : 1950)
Gravano DM, Al-Kuhlani M, Davini D, et al. (2016) CD8(+) T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure. Journal of Autoimmunity
Hoyer KK, Dooms H, Barron L, et al. (2008) Interleukin-2 in the development and control of inflammatory disease. Immunological Reviews. 226: 19-28
Xu J, Gowen L, Raphalides C, et al. (2006) Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse. Diabetes. 55: 3372-80
Shen RR, Ferguson DO, Renard M, et al. (2006) Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood. 108: 1991-8
Hoyer KK, Herling M, Bagrintseva K, et al. (2005) T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation. Journal of Immunology (Baltimore, Md. : 1950). 175: 864-73
See more...